Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
3.115
+0.045 (1.47%)
Apr 29, 2026, 10:30 AM EDT - Market open
Rezolute Market Cap
Rezolute has a market cap or net worth of $323.56 million as of April 29, 2026. Its market cap has increased by 116.43% in one year.
Market Cap
323.56M
Enterprise Value
187.23M
1-Year Change
116.43%
Ranking
Category
Stock Price
$3.12
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $323.56M, an increase of 93.75%. That is a compound annual growth rate of 12.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 293.80M | 34.28% |
| Dec 31, 2025 | 218.80M | -22.93% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compass Therapeutics | 331.36M |
| Nautilus Biotechnology | 327.80M |
| Bicycle Therapeutics | 326.93M |
| Palisade Bio | 326.48M |
| Inhibikase Therapeutics | 320.45M |
| Cabaletta Bio | 318.38M |
| Greenwich LifeSciences | 315.88M |
| NervGen Pharma | 314.01M |